Publications

Pashkov VN, Westphalen RI, Hemmings HC.  2002.  General anesthetics do not affect release of the neuropeptide cholecystokinin from isolated rat cortical nerve terminals.. Anesthesiology. 97(6):1500-6.

Pashkov VN, Hemmings HC.  2002.  The effects of general anesthetics on norepinephrine release from isolated rat cortical nerve terminals.. Anesth Analg. 95(5):1274-81,tableofcontents.

OuYang W, Herold KF, Hemmings HC.  2009.  Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function.. Anesthesiology. 110(3):582-90.

Ouyang W, Wang G, Hemmings HC.  2004.  Distinct rat neurohypophysial nerve terminal populations identified by size, electrophysiological properties and neuropeptide content.. Brain Res. 1024(1-2):203-11.

OuYang W, Hemmings HC.  2005.  Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals.. J Pharmacol Exp Ther. 312(2):801-8.

OuYang W, Hemmings HC.  2007.  Isoform-selective effects of isoflurane on voltage-gated Na+ channels.. Anesthesiology. 107(1):91-8.

OuYang W, Wang G, Hemmings HC.  2003.  Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals.. Mol Pharmacol. 64(2):373-81.

OuYang W, Jih T-Y, Zhang T-T, Correa AM, Hemmings HC.  2007.  Isoflurane inhibits NaChBac, a prokaryotic voltage-gated sodium channel.. J Pharmacol Exp Ther. 322(3):1076-83.

Ouimet CC, Miller PE, Hemmings HC, Walaas SI, Greengard P.  1984.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.. J Neurosci. 4(1):111-24.

Ouimet CC, Hemmings HC, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain.. J Neurosci. 9(3):865-75.

Ouimet CC, Hemmings HC, Greengard P.  1988.  Dopamine-regulated protein phosphorylation in the basal ganglia.. Adv Exp Med Biol. 235:1-17.

Nguyen C, Nishi A, Kansy JW, Fernandez J, Hayashi K, Gillardon F, Hemmings HC, Nairn AC, Bibb JA.  2007.  Regulation of protein phosphatase inhibitor-1 by cyclin-dependent kinase 5.. J Biol Chem. 282(22):16511-20.

New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V, Sprung L, Shaw RB, Koenigsberg H, Platholi J et al..  2002.  Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.. Arch Gen Psychiatry. 59(7):621-9.

Nairn AC, Hemmings HC, Greengard P.  1985.  Protein kinases in the brain.. Annu Rev Biochem. 54:931-76.

Nairn AC, Hemmings HC, Walaas SI, Greengard P.  1988.  DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons.. J Neurochem. 50(1):257-62.

Murugaiah KD, Hemmings HC.  1998.  Effects of intravenous general anesthetics on [3H]GABA release from rat cortical synaptosomes.. Anesthesiology. 89(4):919-28.

Morrow PW, Tung HYLim, Hemmings HC.  2004.  Rapamycin causes activation of protein phosphatase-2A1 and nuclear translocation of PCNA in CD4+ T cells.. Biochem Biophys Res Commun. 323(2):645-51.

Meister B, Fried G, Hökfelt T, Hemmings HC, Greengard P.  1988.  Immunohistochemical evidence for the existence of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in brown adipose tissue of pigs.. Proc Natl Acad Sci U S A. 85(22):8713-6.

Meister B, Arvidsson U, Hemmings HC, Greengard P, Hökfelt T.  1991.  Dopamine- and adenosine-3':5'-monophosphate (cAMP)-regulated phosphoprotein of Mr 32,000 (DARPP-32) in the retina of cat, monkey and human.. Neurosci Lett. 131(1):66-70.

Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.  1989.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.

Meister B, Schultzberg M, Hemmings HC, Greengard P, Goldstein M, Hökfelt T.  1991.  Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization.. J Auton Nerv Syst. 36(1):75-84.

Meister B, Askergren J, Tunevall G, Hemmings HC, Greengard P.  1991.  Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.. J Endocrinol Invest. 14(8):655-61.

McAvoy T, Allen PB, Obaishi H, Nakanishi H, Takai Y, Greengard P, Nairn AC, Hemmings HC.  1999.  Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation.. Biochemistry. 38(39):12943-9.

Mayerhofer A, Hemmings HC, Snyder GL, Greengard P, Boddien S, Berg U, Brucker C.  1999.  Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.. J Clin Endocrinol Metab. 84(1):257-64.

Matovcik LM, Hemmings HC, Kinder BK.  1995.  DARPP-32 (dopamine and cAMP-regulated phosphoprotein, M(r) 32,000) is a membrane protein in the bovine parathyroid.. FEBS Lett. 364(1):67-74.